adult care across the spectrum of respiratory conditions [15]. These narratives were gathered
from a range of European countries to represent the variance of experience across the region and
highlight patient-centred takeaways on the topic, supported by key findings from the literature
and anecdotal narratives from people with a lived experience of transition of care.
We hope that this Monograph will offer a useful insight into adolescent health, and we are very
grateful to our many distinguished contributors for their help in creating this book.
References
1 Sawyer S, Drew S, Duncan R. Adolescents with chronic disease -the double whammy. Aust Fam Physician 2007
36: 622–627.
2 Forsyth V. Adolescent health: a brief introduction. In: Nanzer AM, Barry PJ, Kent BD, eds. The Transition of
Respiratory Care: from Child to Adult (ERS Monograph). Sheffield, European Respiratory Society, 2024 pp. 1–11.
3 Hagell A, McKeown R. Health inequalities and the social determinants of adolescent health. In: Nanzer AM,
Barry PJ, Kent BD, eds. The Transition of Respiratory Care: from Child to Adult (ERS Monograph). Sheffield,
European Respiratory Society, 2024 pp. 12–22.
4 Brandreth RA, Semple C, Dias R, et al. Obesity and complications of excess weight in children and young
people. In: Nanzer AM, Barry PJ, Kent BD, eds. The Transition of Respiratory Care: from Child to Adult (ERS
Monograph). Sheffield, European Respiratory Society, 2024 pp. 23–37.
5 Steward-Knight K, Carroll S. “I just want to get on with my life”: adolescent psychology for respiratory
clinicians. In: Nanzer AM, Barry PJ, Kent BD, eds. The Transition of Respiratory Care: from Child to Adult (ERS
Monograph). Sheffield, European Respiratory Society, 2024 pp. 38–53.
6 Pearce CJ, Azam A, Barry PJ, et al. Adherence to medicine in adolescence. In: Nanzer AM, Barry PJ, Kent BD,
eds. The Transition of Respiratory Care: from Child to Adult (ERS Monograph). Sheffield, European Respiratory
Society, 2024 pp. 54–65.
7 Verhulst S, Van de Perck E, Slaats M, et al. Obstructive sleep apnoea. In: Nanzer AM, Barry PJ, Kent BD, eds.
The Transition of Respiratory Care: from Child to Adult (ERS Monograph). Sheffield, European Respiratory
Society, 2024 pp. 66–77.
8 Tan H-L, Simonds AK. Neuromuscular diseases and long-term ventilation. In: Nanzer AM, Barry PJ, Kent BD,
eds. The Transition of Respiratory Care: from Child to Adult (ERS Monograph). Sheffield, European Respiratory
Society, 2024 pp. 78–94.
9 Riha RL, McLellan A, McPherson J, et al. Transition to adult care of children with narcolepsy and other
disorders of central hypersomnolence. In: Nanzer AM, Barry PJ, Kent BD, eds The Transition of Respiratory
Care: from Child to Adult (ERS Monograph). Sheffield, European Respiratory Society, 2024 pp. 95–106.
10 Douglas H, Marino P. Pulmonary hypertension and congenital heart disease. In: Nanzer AM, Barry PJ, Kent BD,
eds. The Transition of Respiratory Care: from Child to Adult (ERS Monograph). Sheffield, European Respiratory
Society, 2024 pp. 134–143.
11 Sánchez-García S, Garriga-Baraut T, Fernández-de-Alba I. Asthma. In: Nanzer AM, Barry PJ, Kent BD, eds. The
Transition of Respiratory Care: from Child to Adult (ERS Monograph). Sheffield, European Respiratory Society,
2024 pp. 144–165.
12 Connett G. Cystic fibrosis. In: Nanzer AM, Barry PJ, Kent BD, eds. The Transition of Respiratory Care: from Child
to Adult (ERS Monograph). Sheffield, European Respiratory Society, 2024 pp. 107–119.
13 Shawcross A, Shteinberg M. Transitioning from paediatric to adult care in bronchiectasis. In: Nanzer AM, Barry
PJ, Kent BD, eds. The Transition of Respiratory Care: from Child to Adult (ERS Monograph). Sheffield, European
Respiratory Society, 2024 pp. 120–133.
14 Fuchs O, Bahmer T, Rabe KF, et al. Asthma transition from childhood into adulthood. Lancet Respir Med 2017
5: 224–234.
15 Hansen K, Anderson L. Transition of care: the patient perspective. In: Nanzer AM, Barry PJ, Kent BD, eds. The
Transition of Respiratory Care: from Child to Adult (ERS Monograph). Sheffield, European Respiratory Society,
2024 pp. 166–176.
Disclosures: A.M. Nanzer reports receiving payment or honoraria for lectures and educational events from
AstraZeneca, GlaxoSmithKline, Teva and Sanofi, and support for attending conferences from AstraZeneca, Chiesi
and Napp. P.J. Barry reports receipt of speaker fees from Vertex Pharmaceuticals and Chiesi consulting fees from
INSMED and participation in an advisory board with Boehringer Ingelheim. B.D. Kent has participated in advisory
boards and/or received speaker fees from AstraZeneca, Chiesi, GSK, Novartis and Teva has received educational
travel bursaries from Boehringer Ingelheim, Chiesi and Napp and has received research funding from Itamar Medical.
https://doi.org/10.1183/2312508X.10008624 xi
Previous Page Next Page